1. To speed-up and reduce the cost to develop new drugs, researchers
use in silico docking algorithms to compute the probability that potential drugs will dock with a target protein. In silico drug screening can thus accelerate the discovery of novel potent inhibitors by minimising the non-productive trial-and-error approach in a laboratory.
2. For more information on the drug discovery application against the
avian flu virus, please contact Ying-Ta Wu (GRC, Academia Sinica), email: [email protected]
3. For more information about WISDOM (wide in silico docking against
malaria), please visit: http://wisdom.eu-egee.fr/ or contact Vincent Breton (CNRS/IN2P3), email: [email protected]
4. For more information about the end-user environment for large-scale
drug analysis, please visit: http://www.twgrid.org/Application/Bioinformatics/AvainFlu-GAP or contact Hurng-Chun Lee (ASGC), email: [email protected]
5. For more information about the Enabling Grids for E-sciencE
(EGEE) project please see http://www.eu-egee.org/ or contact Sarah Nolan (CERN), EGEE External Relations Officer, telephone: +41 22 767 4176 or email: [email protected]
6. For more information on the Corpuscular Physics Laboratory of
Clermont-Ferrand, CNRS/IN2P3 please see http://clrwww.in2p3.fr/
7. For more information on the Genomics Research Center of
Academia Sinica, Taiwan, please see http://www.genomics.sinica.edu.tw/
8. For more information on the Academia Sinica Grid Computing Team
(ASGC), Taiwan, please see http://www.twgrid.org/
9. For more information on the Institute for Biomedical Technologies,
CNR, Italy, please see http://www.itb.cnr.it/
10. For more information on the AuverGrid please see
11. For more information on EMBRACE, please see
EGEE-II is a project funded by the European Commission - contract number INFSO-RI-031688
12. For more information on the Bioinformatics Grid Application for life
science (BioinfoGRID) project, please see http://www.itb.cnr.it/bioinfogrid
EGEE-II is a project funded by the European Commission - contract number INFSO-RI-031688